# Evaluation of Immunologic Response Following COVID-19 Vaccination in Children, Adolescents, and Young Adults With Cancer

> **NCT05228275** · — · ACTIVE_NOT_RECRUITING · sponsor: **Children's Oncology Group** · enrollment: 549 (estimated)

## Conditions studied

- COVID-19 Infection
- Hematopoietic and Lymphatic System Neoplasm
- Malignant Solid Neoplasm

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **OTHER:** Survey Administration

## Key facts

- **NCT ID:** NCT05228275
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-04-08
- **Primary completion:** 2027-09-30
- **Final completion:** 2028-03-31
- **Target enrollment:** 549 (ESTIMATED)
- **Last updated:** 2026-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05228275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05228275, "Evaluation of Immunologic Response Following COVID-19 Vaccination in Children, Adolescents, and Young Adults With Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05228275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*